This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jiang, W. Articles by Thompson, H. J. Search for Related Content PubMed PubMed Citation Articles by Jiang, W. Articles by Thompson, H. J. Related Collections Preclinical Intervention Preclinical Intervention: In Vivo (Animals): Drugs, Nutritional Interventions, Mechanisms

Dietary Energy Restriction Modulates the Activity of AMP-Activated Protein Kinase, Akt, and Mammalian Target of Rapamycin in Mammary Carcinomas, Mammary Gland, and Liver

Cancer Prevention Laboratory, Colorado State University, Fort Collins, Colorado

Requests for reprints: Henry J. Thompson, Cancer Prevention Laboratory, Colorado State University, 1173 Campus Delivery, Fort Collins, CO 80523. Phone: 970-491-7748; Fax: 970-491-3542; E-mail: henry.thompson{at}colostate.edu.

Key Words: dietary energy restriction • AMP-activated protein kinase • mammalian target of rapamycin • protein kinase B (Akt) • mammary carcinogenesis

Dietary energy restriction (DER) inhibits mammary carcinogenesis, yet mechanisms accounting for its protective activity have not been fully elucidated. In this study, we tested the hypothesis that DER exerts effects on intracellular energy sensing pathways, resulting in alterations of phosphorylated proteins that play a key role in the regulation of cancer. Experiments were conducted using the 1-methyl-1-nitrosourea–induced mammary cancer model in which rats were 0%, 20%, or 40% energy restricted during the postinitiation stage of carcinogenesis. Parallel experiments were done in non–carcinogen-treated rats in which effects of DER at 0%, 5%, 10%, 20%, or 40% in liver were investigated. In a DER dose–dependent manner, levels of Thr¹⁷² phosphorylated AMP-activated protein kinase (AMPK) increased in mammary carcinomas with a concomitant increase in phosphorylated acetyl-CoA-carboxylase, a direct target of AMPK, the phosphorylation of which is regarded as an indicator of AMPK activity. Levels of phosphorylated mammalian target of rapamycin (mTOR) decreased with increasing DER, and down-regulation of mTOR activity was verified by a decrease in the phosphorylation state of two mTOR targets, 70-kDa ribosomal protein S6 kinase (p70S6K) and eukaryote initiation factor 4E binding protein 1 (4E-BP1). Coincident with changes in mTOR phosphorylation, levels of activated protein kinase B (Akt) were also reduced. Similar patterns were observed in mammary glands and livers of non–carcinogen-treated rats. This work identifies components of intracellular energy sensing pathways, specifically mTOR, its principal upstream regulators, AMPK and Akt, and its downstream targets, p70S6K and 4E-BP1, as candidate molecules on which to center mechanistic studies of DER. [Cancer Res 2008;68(13):5492–9]

This article has been cited by other articles:

				K. R. Ong, A. H. Sims, M. Harvie, M. Chapman, W. B. Dunn, D. Broadhurst, R. Goodacre, M. Wilson, N. Thomas, R. B. Clarke, et al. Biomarkers of Dietary Energy Restriction in Women at Increased Risk of Breast Cancer Cancer Prevention Research, August 1, 2009; 2(8): 720 - 731. [Abstract] [Full Text] [PDF]

				J. R. Fay, V. Steele, and J. A. Crowell Energy Homeostasis and Cancer Prevention: The AMP-Activated Protein Kinase Cancer Prevention Research, April 1, 2009; 2(4): 301 - 309. [Abstract] [Full Text] [PDF]

				W. Jiang, Z. Zhu, and H. J. Thompson Effects of Physical Activity and Restricted Energy Intake on Chemically Induced Mammary Carcinogenesis Cancer Prevention Research, April 1, 2009; 2(4): 338 - 344. [Abstract] [Full Text] [PDF]

				S. D. Hursting Mechanistic Insights into Reducing the Weight of Breast Cancer Cancer Prevention Research, April 1, 2009; 2(4): 295 - 297. [Full Text] [PDF]